After receiving $10 million from Apple’s Advanced Manufacturing Fund, COPAN Diagnostics has now shipped more than 15 million COVID-19 sample collection kits for communities across the country. Teams at Apple, COPAN, and more than a dozen other US companies created innovative processes and developed new machinery for COPAN’s Southern California facilities, increasing test-kit production by close to 4,000 percent since April.
“We are proud our Advanced Manufacturing Fund is supporting companies like COPAN who are playing a critical role in the fight against COVID-19 and assisting healthcare professionals and communities across the country,” said Jeff Williams, Apple’s chief operating officer. “This collaboration helped produce, ship, and deliver millions of sample collection kits to hospitals from coast to coast — and we believe it is this unique combination of American manufacturing and innovation that will help us emerge from this crisis and build a safer world for us all.”
Since May, COPAN has shipped those sample collection kits to medical facilities across the country, including hospitals in California, Wisconsin, and Texas.